Michael Rossi

Amministratore Delegato presso Y-MABS THERAPEUTICS, INC.

Patrimonio netto: 1 M $ in data Oggi

53 anni

Health Technology

Health Services

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Thomas Gad	M	54	Y-MABS THERAPEUTICS, INC.	9 anni
Bo Kruse	M	52	Y-MABS THERAPEUTICS, INC.	9 anni
James Healy	M	59	Y-MABS THERAPEUTICS, INC.	7 anni
David Gill	M	69	Y-MABS THERAPEUTICS, INC.	7 anni
Johan Ernst Wedell-Wedellsborg	M	54	Y-MABS THERAPEUTICS, INC.	9 anni
Ashutosh Tyagi	M	47	Y-MABS THERAPEUTICS, INC.	7 anni
Joris Wilms	M	50	Y-MABS THERAPEUTICS, INC.	8 anni
Laura Hamill	F	60	Y-MABS THERAPEUTICS, INC.	4 anni
Torben Lund-Hansen	M	73	Y-MABS THERAPEUTICS, INC.	8 anni
Vignesh Rajah	M	59	Y-MABS THERAPEUTICS, INC.	4 anni
Sue Smith	F	54	Y-MABS THERAPEUTICS, INC.	2 anni

Mostra altro

Relazione in diverse aziende

Nome	Sesso	Età	Società collegate	Collaborazione
Gérard Ber	M	66	Y-MABS THERAPEUTICS, INC.	6 anni
Jyothsna Natauri	F	46	MIRION TECHNOLOGIES, INC.	2 anni
Martyn Coombs	M	-	Jubilant Draximage, Inc. Jubilant Draximage, Inc. Pharmaceuticals: MajorHealth Technology Jubilant DraxImage, Inc. engages in the provision of development, manufacturing, and commercialization of radiopharmaceuticals. Its product Drax Exametazime used for the diagnosis and treatment of disease such as intra-abdominal infection and inflammatory bowel disease. The company is headquartered in Kirkland, Canada.	4 anni
Steen Lisby	M	60	Y-MABS THERAPEUTICS, INC.	7 anni
David Vanevenhoven	M	40	MIRION TECHNOLOGIES, INC.	4 anni

Paese	Relazioni	% del totale
Stati Uniti	13	81.25%
Canada	1	6.25%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni